Maison Solutions Inc. MSS
1.10 USD +0.43 (+63.18%)
Regular-session close
1.14 +0.04 +3.58%
After hours · Nov 20, 7:59 PM ET
0.75 Day range 1.69
0.674 52-week range 27.00
- YTD
- -93.08%
- 1 year
- -94.54%
News
globenewswire.com Terrestar Solutions joins with Equatys, expanding shared satellite infrastructure for global direct-to-device and advanced MSS connectivity while preserving national sovereignty OTTAWA, Ontario, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Space42 (ADX: SPACE42), the UAE-based AI-powered SpaceTech company, and Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite and secure…
gurufocus.com Agenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026 [url="]Agenus Inc. (Nasdaq: AGEN)[/url], a leader in immuno-oncology innovation, today announced early Phase 2 results from the mismatch repair-deficient (dMMR)
gurufocus.com AST SpaceMobile Advances Service Readiness Ahead of Initial Space-Based Cellular Broadband Coverage in Key Global Markets AST SpaceMobile, Inc. (âAST SpaceMobileâ) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly
defenseworld.net Head to Head Contrast: US Foods (NYSE:USFD) & Maison Solutions (NASDAQ:MSS) US Foods (NYSE: USFD - Get Free Report) and Maison Solutions (NASDAQ: MSS - Get Free Report) are both consumer staples companies, but which is the better stock? We will contrast the two companies…
gurufocus.com Agenus to Present BOT+BAL Long-Term Survival Data and Translational Research With agenT-797 in Colorectal Cancer at SITC 2026 [url="]Agenus Inc.[/url] (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that two posters highlighting research on botensilimab (BOT), a
accessnewswire.com Maison Solutions Inc. Receives Additional Nasdaq Notification Regarding Delayed Filing of Quarterly Report on Form 10-Q MONTEREY PARK, CA / ACCESS Newswire / September 29, 2026 / Maison Solutions Inc. (Nasdaq:MSS) (the "Company") today announced that, on September 23, 2026, it received a notification letter from the…
globenewswire.com Oncolytics Biotech® Reports Accelerating Enrollment in Randomized REO 033 RAS-Mutant, MSS Colorectal Cancer Study Substantially all planned REO 033 clinical sites are now activated, with multiple patients currently on study Company expects to have sufficient Part A data to provide an interim clinical update by…
prnewswire.com Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy Paxalisib Monotherapy Significantly Reduced Tumor Burden in Pre-Clinical Model of MSS/pMMR Colorectal Cancer, With the Addition of Pembrolizumab Driving a Further Reduction Paxalisib Was Well…
gurufocus.com Agenus Announces Peer-Reviewed Publication Linking BOT+BAL's Durable Survival in MSS Metastatic Colorectal Cancer to Its Distinct Immune-Priming Mechanism [url="]Agenus[/url] Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the peer-reviewed publication of mature Phase 1b results from t
accessnewswire.com Maison Solutions Eliminates All Outstanding Convertible Notes, Removing Legacy Financing Overhang Completion Removes the Remaining Conversion Overhang Associated With the Company's Convertible Note Financing and, Management Believes, Enhances Financial and Strategic Flexibility MONTEREY PARK, CA…
accessnewswire.com Maison Solutions Inc. Receives Nasdaq Notification Regarding Delayed Filing of Annual Report on Form 10-K MONTEREY PARK, CA / ACCESS Newswire / August 25, 2026 / Maison Solutions Inc. (Nasdaq:MSS) (the "Company") today announced that, on August 20, 2026, it received a notification letter from the Listing…
gurufocus.com ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform" ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program⦠"Expansion of the LMT Platform" PR Newsw
globenewswire.com Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer FDA written feedback provides alignment on a potential pivotal Part B expansion of the ongoing REO 033 study Proposed pathway offers potential accelerated approval based on objective response rate…
gurufocus.com Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combi
accessnewswire.com Maison Solutions Inc. Receives 2026 Global Recognition Award in Innovation Category MONTEREY PARK, CA / ACCESS Newswire / August 5, 2026 / Maison Solutions Inc. (Nasdaq:MSS) ("Maison Solutions" or the "Company"), a specialty grocery retailer offering traditional Asian food and…
accessnewswire.com Maison Solutions Issues Letter to Shareholders on Operational Reset, Recent Transaction Value and the Company's Path Forward MONTEREY PARK, CA / ACCESS Newswire / July 29, 2026 / Maison Solutions Inc. (Nasdaq:MSS) ("Maison Solutions" or the "Company"), a specialty grocery retailer offering traditional Asian food and…
accessnewswire.com Maison Solutions Regains Compliance with Nasdaq Annual Meeting Requirement MONTEREY PARK, CA / ACCESS Newswire / July 27, 2026 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a specialty grocery retailer offering traditional Asian food and…
accessnewswire.com Maison Solutions Signs Definitive Agreement to Establish Majority-Controlled AI Technology Platform MONTEREY PARK, CA / ACCESS Newswire / July 24, 2026 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a specialty grocery retailer offering traditional Asian food and…
gurufocus.com Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Adv
accessnewswire.com Maison Solutions Announces Reverse Stock Split MONTEREY PARK, CA / ACCESS Newswire / July 20, 2026 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a specialty grocery retailer offering traditional Asian food and…
